New DMD drug approved in US

Country

United States

The Food and Drug Administration has approved a second drug for the treatment of Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes a progressive deterioration of muscle. The treatment is a corticosteroid called Emflaza (deflazacort) that works by decreasing inflammation and reducing the activity of the immune system.